TB Archives – Page 11 of 49 – Treatment Action Group

TAG Submission to WHO Public Hearing Regarding a New International Instrument on Pandemic Preparedness and Response

April 13, 2022
Dorrit Walsh

At the first of these two public hearings TAG submitted the following statement with six reasons why the new international instrument must explicitly acknowledge the right to science as a central guiding framework.

Community-led Monitoring for Access to Tuberculosis Screening and Diagnostic Testing

April 7, 2022
Dorrit Walsh

People at risk of tuberculosis (TB) have a right to TB screening and diagnostic testing in accordance with the standard of care recommended by the World Health Organization (WHO). Yet, many countries with high burdens of TB have limited uptake…

CROI 2022 TB Round Up

March 22, 2022
Dorrit Walsh

Treatment Action Group welcomes the tuberculosis (TB) data reported at the 2022 Conference on Retroviruses and Opportunistic Infections (CROI). This is a summary of major findings — and TAG’s take on them.

The Right to Prevent TB

March 17, 2022
Dorrit Walsh

It’s now easier than ever to prevent TB before it develops into active disease or spreads within communities.

Mourning Paul Farmer, Honoring His Legacy

February 23, 2022
Dorrit Walsh

TAG’s staff and board of directors are filled with grief at the premature death of Dr. Paul Farmer, who illuminated and changed our world with his combination of passion, intelligence, solidarity with the poor, and determined will for social justice.

European Commitments to TB R&D Investments: Promises Made to Be Broken?

February 18, 2022
Dorrit Walsh

In this brief, TAG outlines the pathway the EU can take to scale up support for TB R&D, and advance the many European-sponsored TB vaccine candidates currently in the development pipeline.

TB Vaccine Advocacy Roadmap Calls for Increased EU Funding for TB Vaccine Development

February 16, 2022
Dorrit Walsh

TAG stands proudly alongside the TB community to issue this press statement calling for increasing European funding for TB vaccine development, just before the sixth Global Forum on TB Vaccines convenes in Toulouse, France.

Submission to the Office of the High Commissioner for Human Rights Input to HRC resolution 47/17

February 15, 2022
Dorrit Walsh

On February 9, TAG submitted this testimony to the Office of the High Commission for Human Rights (OHCHR) to inform its upcoming report to the Human Rights Council (HRC) on 'human rights in the context of HIV/AIDS' (HRC resolution 47/17).

2021 TAG Update

December 16, 2021
Dorrit Walsh

As we look forward to an end of an extremely challenging year—and past four years—we reflect on the remarkable resilience and impact of TAG, even and especially in these dark times.

Cover of Tuberculosis Research Funding Trends, 2005 - 2020. Cover illustration is a sheet of stamps. one says Institut pasteur, 1921-2021, le vaccin protege bcg vaccine protects. the second says 2021, invest in new end TB vaccines, 2030

2021 Report on TB Research Funding Trends

December 9, 2021
Dorrit Walsh

TAG’s latest report on global funding for TB research and development (R&D), published in collaboration with the Stop TB Partnership, presents new data on TB R&D funding in 2020 and analyzes trends in funding since 2005.